Síndrome Coronariana Aguda (SCA) associada ao abuso de cocaína: uma revisão narrativa / Acute Coronary Syndrome (ACS) associated with cocaine abuse: a narrative review

Laerte de Paiva Viana Filho, Abner Fernandes da Silva, Alice Freitas Macedo, Ana Flávia Oliveira Aquino Gusmão, Clarissa Moreira Teatini, João Pedro Costa dos Santos, José Igor Araújo Lima Verde Santos, Larissa Maia Lemos Barreto

Abstract


Objetivo: Descrever o manejo do paciente com síndrome coronariana aguda (SCA) associada ao abuso de cocaína, com ênfase nos efeitos tóxicos da droga, no quadro clínico, no diagnóstico e no tratamento. Referencial bibliográfico: A cocaína é uma causa comum de complicações cardiovasculares no departamento de emergência. Isso decorre, em grande parte, devido a seus efeitos cardiotóxicos, que predispõem à isquemia miocárdica, tais como o aumento de fatores pró-coagulantes e o aumento da demanda do músculo cardíaco. Na apresentação clínica, o paciente usuário de cocaína com SCA manifesta a dor torácica como sintoma predominante, de forma similar ao não usuário. Porém, naquele que usou a cocaína, é mais frequente a presença de complicações associadas. Para a avaliação da dor, são solicitados o eletrocardiograma e os biomarcadores seriados, preferencialmente a troponina, como exames iniciais. Quanto ao tratamento, há divergências na literatura, principalmente, em relação ao uso de betabloqueadores nos usuários de cocaína, sendo as demais condutas para SCA aceitáveis, adicionando-se a estas, o uso de benzodiazepínicos. Considerações finais: A SCA induzida pelo uso da cocaína é uma patologia grave e exige mais estudos a respeito de seu tratamento, especialmente acerca da administração de betabloqueadores.


Keywords


Abuso de cocaína, Síndrome Coronariana Aguda, Infarto do Miocárdio

References


RICHARDS, J.R.; HOLLANDER, J.E.; RAMOSKA, E.A.; FAREED, F.N.; SAND, I.C.; IZQUIERDO, G.M.M. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. J Cardiovasc Pharmacol Ther, v. 22, n 3. p. 239–249, 2017.

ABDALLA, R.R.; MADRUGA, C.S.; RIBEIRO, M.; PINSKY, I.; CAETANO, R.; LARANJEIRA, R. Prevalence of Cocaine Use in Brazil: Data from the II Brazilian National Alcohol and Drugs Survey (BNADS). Addict Behav, v. 39, n 1. p. 297-301, 2014.

PHAM, D.; ADDISON, D.; KAYANI, W.; MISRA, A.; JNEID, H.; RESAR, J. Outcomes of beta blocker use in cocaine-associated chest pain: A meta-analysis. Emerg Med J, v. 35, n 9. p. 559-563, 2018.

RYAN, S.A. Cocaine Use in Adolescents and Young Adults. Pediatr Clin North Am, v. 66, n 6. p. 1135-1147, 2019.

SOFUOGLU, M.; SEWELL, R.A. Norepinephrine and stimulant addiction. Addict Biol, v. 14, n 2. p. 119-129, 2009.

TALARICO, G.P.; CROSTA, M.L.; GIANNICO, M.B.; SUMMARIA, F.; CALO, L.; PATRIZI, R. Cocaine and coronary artery diseases: A systematic review of the literature. J Cardiovasc Med, v. 18, n 5. p. 291-294, 2017.

SMITH, J.N.; NEGRELLI, J.M.; MANEK, M.B.; HAWES, E.M.; VIERA, A.J. Diagnosis and management of acute coronary syndrome: An evidence-based update. J Am Board Fam Med, v. 28, n 2. p. 283-293, 2015.

EISEN, A.; GIUGLIANO, R.P.; BRAUNWALD, E. Updates on acute coronary syndrome: A review. JAMA Cardiol, v. 1, n 6. p. 718-730, 2016.

FONSECA, I. Diagnóstico Das Síndromes Coronarianas Agudas E Modelo Sistematizado De Atendimento Em Unidades De Dor Torácica. Soc Cardiol Estado São Paulo, v. 26, n 2. p. 72-85, 2016.

AVEZUM, a.; FELDMAN, A.; CARVALHO, A.C.D.C.; SOUSA, A.C.S.; MANSUR, A.D.P.; BOZZA, A.E.Z. V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras Cardiol, v. 105, n 2. p. 1-105, 2015.

CAREY, M.G. Acute Coronary Syndrome and ST Segment Monitoring. Crit Care Nurs Clin North Am, v. 28, n 3. p. 347-355, 2016.

LUCENA, J.; BLANCO, M.; JURADO, C.; RICO, A.; SALGUERO ,M.; VAZQUEZ, R. Cocaine-related sudden death: A prospective investigation in south-west Spain. Eur Heart J, v. 31, n 3. p. 318-329, 2010.

DAMODARAN, S. Cocaine and beta-blockers: The paradigm. Eur J Intern Med, v. 21, n 2. p. 84-86, 2010.

FUKUSHIMA, A.R.; CORREA, L.T.; MUNOZ, J.W.P.; RICCI, E.L.; CARVALHO, V.M.; CARVALHO, D.G. Crack cocaine, a systematic literature review. Forensic Res Criminol Int J, v. 7, n 5. p. 247-253, 2019.

ZAREI, S.; SALIMI, Y.; REPO, E.; DAGLIOGLU, N.; SAFAEI, Z.; GÜZEL, E. A global systematic review and meta-analysis on illicit drug consumption rate through wastewater-based epidemiology. Environ Sci Pollut Res. 2020.

CARRILLO, X.; CURÓS, A.; MUGA, R.; SERRA, J.; SANVISENS, A.; BAYES-GENIS, A. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes. Eur Heart J, v. 32, n 10. p. 1244-1250, 2011.

GUPTA, N.; WASHAM, J.B.; MOUNTANTONAKIS, S.E.; LI, S.; ROE, M.T.; DE LEMOS, J.A. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome. Am J Cardiol, v. 113, n 5. p. 749-756, 2014.

MCCORD, J.; JNEID, H.; HOLLANDER, J.E.; DE LEMOS, J.A.; CERCEK, B.; HSUE, P. Management of cocaine-associated chest pain and myocardial infarction: A scientific statement from the American Heart Association acute cardiac care committee of the council on clinical cardiology. Circulation, v. 117, n 14. p. 1897-1907, 2008.

BOSCH, X.; LOMA-OSORIO, P.; GUASCH, E.; NOGUÉ, S.; ORTIZ, J.T.; SÁNCHEZ, M. Prevalence, Clinical Characteristics and Risk of Myocardial Infarction in Patients with Cocaine-Related Chest Pain. Rev Española Cardiol, v. 63, n 9. p. 1028-1034, 2010.

MAKKI, N.; BRENNAN, T.M.; GIROTRA, S. Acute coronary syndrome. J Intensive Care Med, v. 30, n 4. p. 186-200, 2015.

STANKOWSKI, R.V.; KLONER, R.A.; REZKALLA, S.H. Cardiovascular consequences of cocaine use. Trends Cardiovasc Med, v. 25, n 6. p. 517-526, 2015.

AGRAWAL, P.R.; SCARABELLI, T.M.; SARAVOLATZ, L.; KINI, A.; JALOTA, A.; CHEN-SCARABELLI, C. Current strategies in the evaluation and management of cocaine-induced chest pain. Cardiol Ver, v. 23, n 6. p. 303-311, 2015.

MARAJ, S.; FIGUEREDO, V.M.; MORRIS, D.L. Cocaine and the heart. Clin Cardiol, v. 33, n 5. p. 264-269, 2010.

BARSTOW, C.; RICE, M.; MCDIVITT, J.D. Acute coronary syndrome: Diagnostic evaluation. Am Fam Physician, v. 95, n 3. p. 170-177, 2017.

THOMSETT, R.; CULLEN, L. The assessment and management of chest pain in primary care. Ajgp, v. 47, n 5. p. 246-251, 2018.

SHUVY, M.; ATAR, D.; GABRIEL, S.P.; HALVORSEN, S.; JOLLY, S.; YUSUF, S. Oxygen therapy in acute coronary syndrome: Are the benefits worth the risk? Eur Heart J, v. 34, n 22. p. 1630-1635, 2013.

STUB, D.; SMITH, K.; BERNARD, S.; NEHME, Z.; STEPHENSON, M.; BRAY, J.E. Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation, v. 131, n 24. p. 2143-2150, 2015.

O’GARA, P.T.; KUSHNER, F.G.; ASCHEIM, D.D.; CASEY, D.E.; CHUNG, M.K.; DE LEMOS, J.A. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol, v. 61, n 4. p. 78-140, 2013.

DUARTE, G.S.; NUNES-FERREIRA, A.; RODRIGUES, F.B.; PINTO, F.J.; FERREIRA, J.J.; COSTA, J. Morphine in acute coronary syndrome: Systematic review and meta-analysis. BMJ Open, v. 9, n 3. p. 1-10, 2019.

HOLLANDER, J.E.; HENRY, T.D. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin, v. 24, n 1. p. 103-114, 2006.

MEINE, T.J.; ROE, M.T.; CHEN, A.Y.; PATEL, M.R.; WASHAM, J.B.; OHMAN, E.M. Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. Am Heart J, v. 149, n 6. p. 1043-1049, 2005.

DJARV, T.; SWAIN, J.M.; CHANG, W.T.; ZIDEMAN, D.A.; SINGLETARY, E. Early or First Aid Administration Versus Late or In-hospital Administration of Aspirin for Non-traumatic Adult Chest Pain: A Systematic Review. Cureus, v. 12, n 2. 2020.

CEDIEL, G.; CARRILLO, X.; GARCÍA-GARCÍA, C.; RUEDA, F.; OLIVERAS, T.; LABATA, C. β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study. Int J Cardiol, v. 260, p. 7-10, 2018.

FANARI, Z.; KENNEDY, K.K.; LIM, M.J.; LADDU, A.A.; STOLKER, J.M. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain. Am J Cardiol, v. 113, n 11. p. 1802-1806, 2014.

SHIN, D.; LEE, E.S.; BOHRA, C.; KONGPAKPAISARN, K. In-Hospital and Long-Term Outcomes of Beta-Blocker Treatment in Cocaine Users: A Systematic Review and Meta-analysis. Cardiol Res, v. 10, n 1. p. 40-47, 2019.

RICHARDS, J.R.; GARBER, D.; LAURIN, E.G.; ALBERTSON, T.E.; DERLET, R.W.; AMSTERDAM, E.A. Treatment of cocaine cardiovascular toxicity: A systematic review. Clin Toxicol, v. 54, n 5. p. 345-364, 2016.

SWITAJ, T.L.; CHRISTENSEN, S.R.; BREWER, D.M. Acute coronary syndrome: Current treatment. Am Fam Physician, v. 95, n 4. p. 232-240, 2017.

KEELEY, E.C.; BOURA, J.A.; GRINES, C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet, v. 361, n 9351. p. 13-20, 2003.

FINKEL, J.B.; MARHEFKA, G.D. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc, v. 86, n 12. p. 1198-1207, 2011.

CHEN, C.W.R.; MAKKIYA, M.; ARONOW, W.; SPEVACK, D.M. Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction. Arch Med Sci, v. 16, n 1. p. 66-70, 2020.




DOI: https://doi.org/10.34119/bjhrv3n4-367

Refbacks

  • There are currently no refbacks.